{"name":"HRYZ Biotech Co.","slug":"hryz-biotech-co","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PD1 antibody","genericName":"PD1 antibody","slug":"pd1-antibody","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]}],"pipeline":[{"name":"PD1 antibody","genericName":"PD1 antibody","slug":"pd1-antibody","phase":"phase_3","mechanism":"PD1 antibody works by binding to the PD-1 receptor on T cells, blocking its interaction with PD-L1 and allowing the immune system to attack cancer cells.","indications":["Non-small cell lung cancer, PD-L1 positive","Melanoma","Head and neck squamous cell carcinoma","Urothelial carcinoma","Renal cell carcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPNjJBXzE5X0pwT3BfalJmLUZ4djRzczM5UEFnWldGSzl6Mkl3Rl81M09wODBaaFBmczNDNkxMWS1Ib05SeV9hUS0zLVZGc05LcnJHYk5OMk9MS3RGVDBKMVR1M1ZhRjdyMVdsbloxYzVnaTJiVlZaaDlfVThseFpSVDRnelUwLVUtUERIVEo5ZUV5b1daclQ2T2d0eFlkWWJaY2dSNWNIcWJsTmdvMDlzdUFacTZ5czczX19CX1dvbS13OV9wZ0lxOHBNWXYtc0RhWXNQNjlBdGpzaGZ4eklUQmNIX3Q3ZXN2ejczZzNlSHo4YWg5aVcyeDBYUjktdlE?oc=5","date":"2025-10-20","type":"pipeline","source":"prnewswire.com","summary":"Liposarcoma Market Set to Grow at a Steady CAGR by 2034 Amid Increasing Clinical Research Activities | DelveInsight - prnewswire.com","headline":"Liposarcoma Market Set to Grow at a Steady CAGR by 2034 Amid Increasing Clinical Research Activities | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBxUHVIZGNBRWQ0TFdOYnBuVHkwb2wtRlFFX28xSC1OcERjSzJiV2pIY29VQVQ3bDc4UnlmRnNhQjNmVW9FSV91d0ZYRW40TS0xajJhSzBtLVRKcDNCYUtidmFKWXBMZEdsaVFjd0xtaHJWaFVmMjRYOHNtQUl2azQ?oc=5","date":"2025-04-03","type":"pipeline","source":"PharmTech.com","summary":"Engineered T Cell Receptor-T Cell Therapies - PharmTech.com","headline":"Engineered T Cell Receptor-T Cell Therapies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}